How big is the Neurostimulation Devices Market?

The Neurostimulation Devices Market size is expected to reach USD 8.21 billion in 2024 and grow at a CAGR of 12.5% to reach USD 14.82 billion by 2029. Read More

What is the current Neurostimulation Devices Market size?

In 2024, the Neurostimulation Devices Market size is expected to reach USD 8.21 billion. Read More

Who are the key players in Neurostimulation Devices Market?

Boston Scientific Corporation, Abbott, Neuronetics, Medtronic and Bayer AG are the major companies operating in the Neurostimulation Devices Market. Read More

Which is the fastest growing region in Neurostimulation Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Neurostimulation Devices Market?

In 2024, the North America accounts for the largest market share in Neurostimulation Devices Market. Read More

What years does this Neurostimulation Devices Market cover, and what was the market size in 2023?

In 2023, the Neurostimulation Devices Market size was estimated at USD 7.18 billion. The report covers the Neurostimulation Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Neurostimulation Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Neurostimulation Devices Market Share

Statistics for the 2023 & 2024 Neurostimulation Devices market share, created by Mordor Intelligence™ Industry Reports. Neurostimulation Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Neurostimulation Devices Industry

The neurostimulation devices market is fragmented in nature due to the presence of several companies operating globally. The key players adopt various strategies to maintain their market positions, such as acquisitions, partnerships, and heavy investments in research and development activities and new product launches. The major players include Abbott, Bayer AG, Boston Scientific Corporation, Laborie, LivaNova PLC, Neuronetics, NeuroPace Inc., Nevro Corp., Medtronic, and Synapse Biomedical Inc.